Search all trials

Find therapies in clinical trials near you – page 2

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Myelodysplastic syndrome+2

Recruiting

Registered drugNo placebo

Study on Ivosidenib for Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome with IDH1 Mutation After Stem Cell Transplant

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Ivosidenib

Contact Research Centre

Myelodysplastic syndrome+1

Recruiting

Investigational

Study of Elritercept for Treating Anemia in Adults with Low to Intermediate Risk Myelodysplastic Syndromes

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Elritercept

Contact Research Centre

Myelodysplastic syndrome+1

Recruiting

Registered drugNo placebo

Study Comparing Treosulfan and Melphalan with Fludarabine for Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Undergoing Transplantation

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Fludarabine

Contact Research Centre

Myelodysplastic syndrome

Recruiting

Registered drugNo placebo

Study on Luspatercept for Treating Anemia in Patients with Myelodysplastic Syndromes (MDS) with del5q, Resistant to Prior Treatments and Needing Blood Transfusions

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Luspatercept

Contact Research Centre

Myelodysplastic syndrome

Recruiting

Registered drugNo placebo

Study on Ivosidenib and Azacitidine for Adults with Myelodysplastic Syndromes and IDH1 Mutation

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Myelodysplastic syndrome

Recruiting

InvestigationalNo placebo

Study on the Safety and Effects of ION440 for Patients with MECP2 Duplication Syndrome

InvestigationalNo placebo

Austria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Ion440

Contact Research Centre

Myelodysplastic syndrome

Recruiting

Registered drugNo placebo

Study of Azacitidine and Drug Combination Before Stem Cell Transplantation in Patients with High-Risk Myelodysplastic Syndrome

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Myelodysplastic syndrome+1

Recruiting

InvestigationalNo placebo

Study of Elritercept for Treating Anemia in Patients with Low to Intermediate Risk Myelodysplastic Syndromes (MDS)

InvestigationalNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Elritercept

Contact Research Centre

Myelodysplastic syndrome+3

Recruiting

InvestigationalNo placebo

Title: Long-term treatment study of oral decitabine and cedazuridine combination for patients with AML, MDS, CMML, or solid tumors who previously received ASTX727

InvestigationalNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Cedazuridine

Contact Research Centre

Myelodysplastic syndrome+4

Recruiting

Registered drugNo placebo

Study on Long-Term Safety of Luspatercept for Patients with Myelodysplastic Syndrome, Beta-Thalassemia, or Myelofibrosis Who Previously Participated in Luspatercept Trials

Registered drugNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Luspatercept

Contact Research Centre

Myelodysplastic syndrome

Recruiting

Registered drugNo placebo

Study on Azacitidine for Patients with Myelodysplastic Syndrome After Stem Cell Transplantation

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Myelodysplastic syndrome+1

Recruiting

Registered drugNo placebo

Study Comparing Thymoglobulin and Grafalon for Preventing Graft Versus Host Disease in Elderly Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Ciclosporin

Contact Research Centre

Find therapies in clinical trials near you – page 2

53 trials match your criteria

Myelodysplastic syndrome+2

Study on Ivosidenib for Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome with IDH1 Mutation After Stem Cell Transplant

Myelodysplastic syndrome+1

Study of Elritercept for Treating Anemia in Adults with Low to Intermediate Risk Myelodysplastic Syndromes

Myelodysplastic syndrome+1

Study Comparing Treosulfan and Melphalan with Fludarabine for Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Undergoing Transplantation

Myelodysplastic syndrome

Study on Luspatercept for Treating Anemia in Patients with Myelodysplastic Syndromes (MDS) with del5q, Resistant to Prior Treatments and Needing Blood Transfusions

Myelodysplastic syndrome

Study on Ivosidenib and Azacitidine for Adults with Myelodysplastic Syndromes and IDH1 Mutation

Myelodysplastic syndrome

Study on the Safety and Effects of ION440 for Patients with MECP2 Duplication Syndrome

Myelodysplastic syndrome

Study of Azacitidine and Drug Combination Before Stem Cell Transplantation in Patients with High-Risk Myelodysplastic Syndrome

Myelodysplastic syndrome+1

Study of Elritercept for Treating Anemia in Patients with Low to Intermediate Risk Myelodysplastic Syndromes (MDS)

Myelodysplastic syndrome+3

Title: Long-term treatment study of oral decitabine and cedazuridine combination for patients with AML, MDS, CMML, or solid tumors who previously received ASTX727

Myelodysplastic syndrome+4

Study on Long-Term Safety of Luspatercept for Patients with Myelodysplastic Syndrome, Beta-Thalassemia, or Myelofibrosis Who Previously Participated in Luspatercept Trials

Myelodysplastic syndrome

Study on Azacitidine for Patients with Myelodysplastic Syndrome After Stem Cell Transplantation

Myelodysplastic syndrome+1

Study Comparing Thymoglobulin and Grafalon for Preventing Graft Versus Host Disease in Elderly Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.